These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20659722)

  • 1. Informed consent and phase 1 research in spinal cord injury.
    Stenson K; Chen D; Tansey K; Kerkhoff TR; Butt L; Gallegos AJ; Kirschner KL
    PM R; 2010 Jul; 2(7):664-70. PubMed ID: 20659722
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicians' understanding of consent requirements for phase I clinical trials in cognitively impaired or highly vulnerable populations.
    Farber NJ; Aboff BM; DeJoseph MR; Castellano J; Weiner J; Boyer EG
    Account Res; 2004; 11(1):63-78. PubMed ID: 15341047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. For phase I studies, ethical and practical concerns abound.
    Travis K
    J Natl Cancer Inst; 2004 Sep; 96(18):1354-5. PubMed ID: 15367565
    [No Abstract]   [Full Text] [Related]  

  • 4. Does research ethics rest on a mistake?
    Miller FG
    Am J Bioeth; 2005; 5(1):34-6; author reply W15-8. PubMed ID: 16036654
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethics and stem cell therapeutics for cardiovascular disease.
    Sugarman J
    Prog Cardiovasc Dis; 2007; 50(1):1-6. PubMed ID: 17631433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A challenging case: how should an IRB rule when a protocol calls for using an extremely vulnerable population: the dying?
    Agich G; Smith D; Levine R
    Prot Hum Subj; 2005; (12):5-6. PubMed ID: 16317856
    [No Abstract]   [Full Text] [Related]  

  • 7. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.
    Horng S; Grady C
    IRB; 2003; 25(1):11-6. PubMed ID: 12833900
    [No Abstract]   [Full Text] [Related]  

  • 8. Translational research beyond approval: a two-stage ethics review.
    Sofaer N; Eyal N
    Am J Bioeth; 2010 Aug; 10(8):W1-3. PubMed ID: 20694895
    [No Abstract]   [Full Text] [Related]  

  • 9. Research versus innovation: real differences.
    Morreim H
    Am J Bioeth; 2005; 5(1):42-3; author reply W15-8. PubMed ID: 16036658
    [No Abstract]   [Full Text] [Related]  

  • 10. The sex kitten of bioethics? Research ethics comes of age.
    Dresser R
    Hastings Cent Rep; 2008; 38(5):5. PubMed ID: 18947127
    [No Abstract]   [Full Text] [Related]  

  • 11. A new era in the ethics of human embryonic stem cell research.
    Lo B; Zettler P; Cedars MI; Gates E; Kriegstein AR; Oberman M; Reijo Pera R; Wagner RM; Wuerth MT; Wolf LE; Yamamoto KR
    Stem Cells; 2005; 23(10):1454-9. PubMed ID: 16293581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic misconception in early phase gene transfer trials.
    Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK
    Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase I clinical trials in oncology: a moral dilemma for the investigators].
    Seligmann M
    Presse Med; 2003 Feb; 32(4):147-8. PubMed ID: 12610469
    [No Abstract]   [Full Text] [Related]  

  • 14. Informed consent in human gene transfer clinical trials.
    Kahn J
    Hum Gene Ther; 2008 Jan; 19(1):7-8. PubMed ID: 18211226
    [No Abstract]   [Full Text] [Related]  

  • 15. Committees for Ethics in Research involving human subjects.
    Hossne WS; Vieira S; De Freitas CB
    J Int Bioethique; 2008; 19(1-2):131-41, 200. PubMed ID: 18664006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How not to rethink research ethics.
    Beauchamp TL
    Am J Bioeth; 2005; 5(1):31-3; author reply W15-8. PubMed ID: 16036653
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment regarding benefit in phase 1 oncology trials.
    Morse M
    Clin Trials; 2008; 5(6):626; discussion 630. PubMed ID: 19029212
    [No Abstract]   [Full Text] [Related]  

  • 18. Varieties of uncertainty and the validity of informed consent.
    Weinfurt KP
    Clin Trials; 2008; 5(6):624-5; discussion 630. PubMed ID: 19029211
    [No Abstract]   [Full Text] [Related]  

  • 19. Case study. Just another test? Commentary.
    Bonifacio HJ
    Hastings Cent Rep; 2010; 40(1):13-4. PubMed ID: 20169651
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I cancer trials. A collusion of misunderstanding.
    Miller M
    Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.